Insider Trading activities of Auxilium Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Auxilium Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Auxilium Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Auxilium Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AUXL. The reporting company's CIK number is 1182129.
The total value of stock buying since 2005 is $86,216,202.
The total value of stock sales since 2005 is $85,896,601.
The total value of stock option exercises since 2005 is $22,897,152.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Auxilium Pharmaceuticals Inc (AUXL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-12 0 $0 499,254 $16,905,025 460,000 $8,504,780
2014-11 0 $0 536,193 $17,881,406 492,724 $9,971,916
2014-03 0 $0 42,032 $1,264,481 41,508 $494,056
2013-12 0 $0 75,669 $1,541,762 75,367 $396,288
2013-08 0 $0 1,900 $35,649 0 $0
2013-05 0 $0 2,000 $30,208 0 $0
2012-12 56,000 $0 0 $0 0 $0
2012-06 0 $0 18,682 $452,463 18,682 $124,651
2012-02 10,000 $200,970 0 $0 0 $0
2011-11 1,610 $25,024 0 $0 0 $0
2011-10 0 $0 5,275 $75,047 5,275 $41,197
2011-07 0 $0 5,275 $107,103 5,275 $41,197
2011-03 1,536,618 $35,014,064 10,555 $242,997 10,555 $82,434
2011-01 0 $0 10,555 $245,055 10,555 $82,434
2010-08 113,599 $2,896,595 0 $0 0 $0
2010-05 0 $0 0 $0 18,750 $107,193
2010-04 0 $0 56,068 $1,937,134 56,068 $352,360
2010-03 135,272 $4,391,953 0 $0 0 $0
2009-09 0 $0 54,883 $1,884,474 41,733 $318,305
2009-07 0 $0 10,883 $341,090 10,333 $77,529
2009-06 0 $0 34,000 $1,017,750 34,000 $253,420
2009-05 0 $0 4,000 $100,092 4,000 $19,120
2009-04 0 $0 4,000 $100,031 4,000 $19,120
2009-03 0 $0 34,933 $1,038,914 34,933 $257,879
2009-02 0 $0 5,300 $168,519 1,850 $24,771
2009-01 0 $0 16,122 $480,188 11,520 $129,375
2008-12 0 $0 16,675 $445,092 5,000 $26,800
2008-08 0 $0 8,750 $350,525 8,750 $115,150
2008-07 0 $0 98,340 $3,547,282 98,340 $918,880
2008-05 0 $0 90,750 $2,763,337 90,750 $447,397
2007-09 0 $0 177,232 $3,552,498 0 $0
2007-08 0 $0 250,374 $5,025,369 0 $0
2007-05 1,510 $20,196 15,000 $199,890 15,000 $90,900
2006-12 0 $0 1,510,000 $24,163,220 0 $0
2006-03 5,500 $35,365 0 $0 0 $0
2005-11 15,000 $73,145 0 $0 0 $0
2005-06 8,889,570 $43,558,890 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Auxilium Pharmaceuticals Inc insiders (AUXL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-12-05 Lurker Nancy (Director) Sale 32,430 34.00 1,102,620
2014-12-05 Lurker Nancy (Director) Option Ex 25,000 19.59 489,750
2014-12-05 Adams Adrian (CEO and President) Sale 40,000 33.97 1,358,720
2014-12-05 Adams Adrian (CEO and President) Option Ex 40,000 17.40 696,000
2014-12-05 Mckee William (Director) Sale 18,000 34.00 612,000
2014-12-05 Mckee William (Director) Option Ex 15,000 30.61 459,150
2014-12-05 Friedman Paul A (Director) Sale 9,689 33.85 327,953
2014-12-04 Friedman Paul A (Director) Sale 20,000 33.67 673,460
2014-12-04 Friedman Paul A (Director) Option Ex 20,000 17.08 341,500
2014-12-03 Fetzer Oliver (Director) Sale 50,000 34.00 1,700,000
2014-12-03 Fetzer Oliver (Director) Option Ex 50,000 22.90 1,144,800
2014-12-02 Fetzer Oliver (Director) Sale 50,000 34.03 1,701,650
2014-12-02 Fetzer Oliver (Director) Option Ex 50,000 14.22 711,000
2014-12-02 Classon Rolf A (Director) Sale 279,135 33.78 9,428,622
2014-12-02 Classon Rolf A (Director) Option Ex 260,000 17.93 4,662,580
2014-11-25 Jobes Elizabeth Varki (Chief Compliance Officer) Sale 27,802 34.04 946,407
2014-11-25 Jobes Elizabeth Varki (Chief Compliance Officer) Option Ex 23,750 17.99 427,262
2014-11-25 Tursi James Patrick (Chief Medical Officer) Sale 13,713 34.12 467,942
2014-11-25 Tursi James Patrick (Chief Medical Officer) Option Ex 10,562 20.17 213,035
2014-11-21 Armstrong Jennifer Lou (Senior Vice President, HR) Sale 75,803 33.50 2,539,097
2014-11-21 Armstrong Jennifer Lou (Senior Vice President, HR) Option Ex 69,412 22.84 1,585,161
2014-11-21 Tursi James Patrick (Chief Medical Officer) Sale 8,648 33.47 289,413
2014-11-21 Tursi James Patrick (Chief Medical Officer) Option Ex 5,000 22.04 110,200
2014-11-21 Koven Andrew I (EVP, CAO, GC and Secretary) Sale 139,683 33.44 4,670,720
2014-11-21 Koven Andrew I (EVP, CAO, GC and Secretary) Option Ex 134,375 19.18 2,577,984
2014-11-20 Tursi James Patrick (Chief Medical Officer) Sale 66,000 33.06 2,181,960
2014-11-20 Tursi James Patrick (Chief Medical Officer) Option Ex 66,000 16.80 1,109,130
2014-11-20 Wills Alan (EVP, Corporate Development) Sale 156,592 33.18 5,195,252
2014-11-20 Wills Alan (EVP, Corporate Development) Option Ex 142,875 21.44 3,062,954
2014-11-20 Glickman Mark A (EVP - Sales and Marketing) Sale 47,952 33.17 1,590,615
2014-11-20 Glickman Mark A (EVP - Sales and Marketing) Option Ex 40,750 21.75 886,190
2014-03-14 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Sale 32,032 29.53 946,001
2014-03-14 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Option Ex 31,508 13.30 419,056
2014-03-05 Classon Rolf A (Director) Sale 10,000 31.85 318,480
2014-03-05 Classon Rolf A (Director) Option Ex 10,000 7.50 75,000
2013-12-13 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Sale 4,602 20.50 94,341
2013-12-13 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Option Ex 4,300 13.16 56,588
2013-12-11 Fickenscher James E (Chief Financial Officer) Sale 71,067 20.37 1,447,421
2013-12-11 Fickenscher James E (Chief Financial Officer) Option Ex 71,067 4.78 339,700
2013-08-15 Fetzer Oliver (Director) Sale 1,900 18.76 35,649
2013-05-20 Mckee William (Director) Sale 2,000 15.10 30,208
2012-12-14 Adams Adrian (CEO and President) Buy 56,000 .00 0
2012-06-25 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Sale 12,682 25.01 317,151
2012-06-25 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Option Ex 12,682 5.50 69,751
2012-06-06 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Sale 6,000 22.55 135,312
2012-06-06 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Option Ex 6,000 9.15 54,900
2012-02-28 Brandt Peter C. (Director) Buy 10,000 20.10 200,970
2011-11-03 Fickenscher James E (Chief Financial Officer) Buy 1,610 15.54 25,024
2011-10-07 Anido Armando (CEO & President) Sale 5,275 14.23 75,047
2011-10-07 Anido Armando (CEO & President) Option Ex 5,275 7.81 41,197
2011-07-08 Anido Armando (CEO & President) Sale 5,275 20.30 107,103
2011-07-08 Anido Armando (CEO & President) Option Ex 5,275 7.81 41,197
2011-03-30 Baker Felix (10% Owner) Buy 3,911 21.98 85,963
2011-03-30 Baker Julian (10% Owner) Buy 309 21.98 6,791
2011-03-29 Baker Julian (10% Owner) Buy 332,000 21.97 7,292,712
2011-03-09 Baker Felix (10% Owner) Buy 782,273 23.12 18,086,151
2011-03-08 Anido Armando (CEO & President) Sale 10,555 23.02 242,997
2011-03-08 Anido Armando (CEO & President) Option Ex 10,555 7.81 82,434
2011-03-08 Baker Felix (10% Owner) Buy 211,909 22.82 4,836,186
2011-01-10 Anido Armando (CEO & President) Sale 10,555 23.22 245,055
2011-01-10 Anido Armando (CEO & President) Option Ex 10,555 7.81 82,434
2010-08-27 Baker Felix (10% Owner) Buy 964 25.80 24,876
2010-08-27 Baker Julian (10% Owner) Buy 34,899 25.80 900,568
2010-08-26 Baker Felix (10% Owner) Buy 2,088 25.36 52,945
2010-08-26 Baker Julian (10% Owner) Buy 75,648 25.36 1,918,206
2010-05-27 Bescherer Edwin A Jr (Director) Option Ex 18,750 5.72 107,193
2010-04-26 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Sale 7,318 35.67 261,062
2010-04-26 Del Tito Benjamin J Jr (EVP, Reg Affairs & Project Mgt) Option Ex 7,318 5.50 40,249
2010-04-19 Bescherer Edwin A Jr (Director) Sale 12,500 36.48 455,962
2010-04-19 Bescherer Edwin A Jr (Director) Option Ex 12,500 4.15 51,874
2010-04-12 Anido Armando (CEO & President) Sale 30,000 33.07 992,129
2010-04-12 Anido Armando (CEO & President) Option Ex 30,000 7.81 234,300
2010-03-11 Baker Felix (10% Owner) Buy 1,805 34.10 61,554
2010-03-11 Baker Julian (10% Owner) Buy 15,367 34.10 524,045
2010-03-10 Baker Felix (10% Owner) Buy 1,203 33.19 39,923
2010-03-10 Baker Julian (10% Owner) Buy 43,597 33.19 1,446,853
2010-03-09 Baker Felix (10% Owner) Buy 1,969 31.64 62,309
2010-03-09 Baker Julian (10% Owner) Buy 71,331 31.64 2,257,269
2009-09-25 Bescherer Edwin A Jr (Director) Sale 27,600 34.83 961,308
2009-09-25 Bescherer Edwin A Jr (Director) Option Ex 15,000 3.71 55,620
2009-09-14 Fickenscher James E (Chief Financial Officer) Sale 4,000 30.70 122,812
2009-09-14 Fickenscher James E (Chief Financial Officer) Option Ex 4,000 4.78 19,120
2009-09-14 Graham Roger D Jr (Executive VP, Sales & Mktg) Sale 12,950 35.21 455,956
2009-09-14 Graham Roger D Jr (Executive VP, Sales & Mktg) Option Ex 12,400 13.39 166,036
2009-09-14 Stacey Jennifer Evans (Executive VP & General Counsel) Sale 6,333 35.43 224,390
2009-09-14 Stacey Jennifer Evans (Executive VP & General Counsel) Option Ex 6,333 9.22 58,409
2009-09-08 Fickenscher James E (Chief Financial Officer) Sale 4,000 30.00 120,008
2009-09-08 Fickenscher James E (Chief Financial Officer) Option Ex 4,000 4.78 19,120
2009-07-24 Graham Roger D Jr (Executive VP, Sales & Mktg) Sale 550 32.00 17,600
2009-07-24 Stacey Jennifer Evans (Executive VP & General Counsel) Sale 6,333 32.13 203,466
2009-07-24 Stacey Jennifer Evans (Executive VP & General Counsel) Option Ex 6,333 9.22 58,409
2009-07-15 Fickenscher James E (Chief Financial Officer) Sale 4,000 30.01 120,024
2009-07-15 Fickenscher James E (Chief Financial Officer) Option Ex 4,000 4.78 19,120
2009-06-26 Anido Armando (CEO & President) Sale 30,000 30.30 908,910
2009-06-26 Anido Armando (CEO & President) Option Ex 30,000 7.81 234,300
2009-06-15 Fickenscher James E (Chief Financial Officer) Sale 4,000 27.21 108,840
2009-06-15 Fickenscher James E (Chief Financial Officer) Option Ex 4,000 4.78 19,120
2009-05-22 Fickenscher James E (Chief Financial Officer) Sale 4,000 25.02 100,092
2009-05-22 Fickenscher James E (Chief Financial Officer) Option Ex 4,000 4.78 19,120
2009-04-17 Fickenscher James E (Chief Financial Officer) Sale 500 25.00 12,500
2009-04-17 Fickenscher James E (Chief Financial Officer) Option Ex 500 4.78 2,390
2009-04-16 Fickenscher James E (Chief Financial Officer) Sale 3,500 25.01 87,531
2009-04-16 Fickenscher James E (Chief Financial Officer) Option Ex 3,500 4.78 16,730
2009-03-16 Fickenscher James E (Chief Financial Officer) Sale 4,933 29.79 146,954
2009-03-16 Fickenscher James E (Chief Financial Officer) Option Ex 4,933 4.78 23,579
2009-03-16 Anido Armando (CEO & President) Sale 30,000 29.73 891,960
2009-03-16 Anido Armando (CEO & President) Option Ex 30,000 7.81 234,300
2009-02-17 Fickenscher James E (Chief Financial Officer) Sale 3,450 31.55 108,837
2009-02-03 Graham Roger D Jr (Executive VP, Sales & Mktg) Sale 1,850 32.26 59,682
2009-02-03 Graham Roger D Jr (Executive VP, Sales & Mktg) Option Ex 1,850 13.39 24,771
2009-01-14 Fickenscher James E (Chief Financial Officer) Sale 3,942 29.04 114,463
2009-01-06 Graham Roger D Jr (Executive VP, Sales & Mktg) Sale 6,210 30.02 186,393
2009-01-06 Graham Roger D Jr (Executive VP, Sales & Mktg) Option Ex 5,550 13.39 74,314
2009-01-06 Stacey Jennifer Evans (Executive VP & General Counsel) Sale 5,970 30.04 179,332
2009-01-06 Stacey Jennifer Evans (Executive VP & General Counsel) Option Ex 5,970 9.22 55,061
2008-12-19 Fickenscher James E (Chief Financial Officer) Sale 11,675 26.31 307,122
2008-12-18 Stacey Jennifer Evans (Executive VP & General Counsel) Sale 5,000 27.59 137,970
2008-12-18 Stacey Jennifer Evans (Executive VP & General Counsel) Option Ex 5,000 5.36 26,800
2008-08-12 Mattila Jyrki (Executive Vice President) Sale 8,750 40.06 350,525
2008-08-12 Mattila Jyrki (Executive Vice President) Option Ex 8,750 13.16 115,150
2008-07-16 Mattila Jyrki (Executive Vice President) Sale 24,000 38.09 914,160
2008-07-16 Mattila Jyrki (Executive Vice President) Option Ex 24,000 12.50 300,000
2008-07-15 Mattila Jyrki (Executive Vice President) Sale 74,340 35.42 2,633,122
2008-07-15 Mattila Jyrki (Executive Vice President) Option Ex 74,340 8.32 618,880
2008-05-07 Mattila Jyrki (Executive Vice President) Sale 90,750 30.45 2,763,337
2008-05-07 Mattila Jyrki (Executive Vice President) Option Ex 90,750 4.93 447,397
2007-09-06 Credit Suisse/ (10% Owner) Sale 116,913 20.11 2,350,886
2007-09-05 Credit Suisse/ (10% Owner) Sale 45,319 20.06 908,872
2007-09-04 Bescherer Edwin A Jr (Director) Sale 15,000 19.52 292,740
2007-08-24 Credit Suisse/ (10% Owner) Sale 193,778 20.07 3,889,318
2007-08-22 Credit Suisse/ (10% Owner) Sale 56,596 20.07 1,136,051
2007-05-08 Fickenscher James E (Chief Financial Officer) Buy 1,510 13.38 20,196
2007-05-08 Altomari Alfred (Director) Sale 15,000 13.33 199,890
2007-05-08 Altomari Alfred (Director) Option Ex 15,000 6.06 90,900
2006-12-05 Soros George (10% Owner) Sale 1,500,000 16.00 24,000,000
2006-12-01 Bescherer Edwin A Jr (Director) Sale 10,000 16.32 163,220
2006-03-10 Kessig Edward F (Vice President, Sales) Buy 3,500 6.43 22,505
2006-03-10 Fickenscher James E (Chief Financial Officer) Buy 1,000 6.43 6,430
2006-03-10 Henwood Geraldine (Chief Executive Officer) Buy 1,000 6.43 6,430
2005-11-28 Stacey Jennifer Evans (General Counsel) Buy 5,000 5.32 26,605
2005-11-22 Classon Rolf A (Director) Buy 5,000 5.09 25,450
2005-11-11 Fickenscher James E (Chief Financial Officer) Buy 5,000 4.22 21,090
2005-06-30 Scp Private Equity Ii Llc (10% Owner) Buy 1,322,112 4.90 6,478,348
2005-06-30 Churchill Winston J (Director) Buy 3,042,081 4.90 14,906,196
2005-06-30 Soros George (10% Owner) Buy 1,224,178 4.90 5,998,472

Insider trading activities including stock purchases, stock sales, and option exercises of AUXL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Auxilium Pharmaceuticals Inc (symbol AUXL, CIK number 1182129) see the Securities and Exchange Commission (SEC) website.